BMRA
BIOMERICA INC
NASDAQ · Healthcare · Medical - Devices · US
$1.76
−4.86%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$1.78
From 52W high−45.00%
Volume13185.00
Market cap$8.09M
P/E (TTM)—
P/S (TTM)1.9x
Div yield—
Key dataOct 19, 2026
Open
$1.78
From 52W high
−45.00%
Volume
13185.00
Market cap
$8.09M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.5x
P/E (TTM)
—
RSI (14)
37.1
MomentumView details →
1D Return
−4.86%
YTD Return
−28.17%
SummaryUpdated Aug 1, 2026
Biomerica, Inc. (NASDAQ:BMRA) is a biomedical technology company founded in 1971 and headquartered in Irvine, California. The company went public in 1984 and has spent over five decades developing, manufacturing, and marketing diagnostic and therapeutic products for medical conditions worldwide. Biomerica operates in the medical devices sector, focusing primarily on diagnostic test kits for gastrointestinal diseases, food intolerances, diabetes, and other medical conditions. The company has evolved from a traditional diagnostic test manufacturer to include therapeutic product development, particularly in the irritable bowel syndrome treatment space.
Similar companies
Latest newsMore news →
Biomerica reported financial results for the first quarter of fiscal 2027, ended August 31, 2026.3d agoDavid Moatazedi departed the board of directors of BIOMERICA INC.4d agoBiomerica, Inc. entered into a Securities Purchase Agreement with certain institutional and individual investors to issue and sell 1,393,705 shares of common stock at $1.60 per share, raising approximately $2.23 million in gross proceeds, with the closing occurring on August 26, 2026.55d ago